Monte Rosa Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $13k | 2.2k | 5.65 |
| 2023-09-30 | $11k | 2.2k | 4.79 |
| 2023-06-30 | $15k | 2.2k | 6.85 |
| 2023-03-31 | $18k | 2.2k | 7.79 |
| 2022-12-31 | $16k | 2.2k | 7.14 |
| 2022-09-30 | $18k | 2.2k | 8.03 |
| 2022-06-30 | $21k | 2.2k | 9.37 |
| 2022-03-31 | $31k | 2.2k | 13.83 |
| 2021-12-31 | $18k | 887 | 20.29 |
| 2021-09-30 | $20k | 887 | 22.55 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors